Search Within

Jaap Jan Boelens

  1. "Barbara Spitzer"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (11)
  3. Research Letter (2)
Groups
  1. Pediatrics, Department of (25)
  2. Stem Cell Transplantation and Cellular Therapy Service (25)
  3. Tow Center for Developmental Oncology (TCDO) (25)
  4. Department of Medicine (22)
  5. GSK Faculty (22)
  6. Immunology Program Faculty (22)

More Groups

People
  1. Barbara Spitzer (25)
  2. Kevin Curran (24)
  3. Maria Cancio (24)
  4. Andromachi Scaradavou (23)
  5. Richard O'Reilly (22)
  6. Nancy Kernan (20)

More People

Years
  1. 2024 (6)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (7)
  6. 2019 (5)
Publications
  1. Bone Marrow Transplantation (6)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Blood (4)
  4. Blood Advances (3)
  5. Cytotherapy (3)
  6. Transplantation and Cellular Therapy (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (6)
  4. Elsevier Science Ltd. (3)
  5. John Wiley & Sons (1)
  6. Mosby Elsevier (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Identification of infants with non-SCID immune deficiency by newborn screening for SCID - The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Prockop, S.; Spitzer, B.; Walsh, M.; Ruggiero, J.; Kennedy, J.; Boulad, F.; Cancio, M.; Curran, K.; Kernan, N.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save